)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Vista Pharmaceuticals
Vista Pharmaceuticals (524711) investor relations material
Vista Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary14 Aug, 2026
Executive summary
Unaudited financial results for the quarter ended June 30, 2026, were approved by the board on August 14, 2026.
The company reported a net loss for the quarter, continuing a multi-year trend of losses.
Financial highlights
Revenue from operations for the quarter was Nil, compared to ₹151.88 lakhs in the same quarter last year.
Loss before tax for the quarter was ₹(132.71) lakhs, versus ₹(148.01) lakhs year-over-year.
Net loss after tax stood at ₹(98.59) lakhs, compared to ₹(129.04) lakhs in the prior year quarter.
Basic and diluted EPS for the quarter were both ₹(0.16), unchanged due to anti-dilutive effect of outstanding warrants.
Current liabilities exceeded current assets by ₹183.32 lakhs as of June 30, 2026.
Outlook and guidance
Management is negotiating debt restructuring and implementing cost rationalization.
A formal financial undertaking from warrant subscribers is expected to provide ₹922.49 lakhs to support operations.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vista Pharmaceuticals
- Audited FY26 results received an unqualified opinion; new internal auditor appointed for FY27.524711
Q4 25/26 - Q3 FY26 saw higher net loss and ECL provision, with statutory dues outstanding.524711Q3 25/26
- Q2 FY26 saw lower revenue, higher losses, and major ECL provisioning amid new capital raised.524711Q2 25/26
- Revenue fell and losses deepened in Q1 FY26, with leadership continuity affirmed.524711Q1 25/26
- Q2 FY25 saw lower revenue but reduced losses and stronger equity from capital raising.524711Q2 24/25
- Q1 FY25 saw lower revenue and a net loss, with AGM scheduled for September 30, 2024.524711Q1 24/25
- Net loss persists despite revenue growth; WHO certification and audit opinion boost credibility.524711Q4 24/25
- Q3 FY25 revenue surged, but losses continued; WHO certification marks a key milestone.524711Q3 24/25
Next Vista Pharmaceuticals earnings date
Q2 26/2712 Nov, 2026
Vista Pharmaceuticals
Next Vista Pharmaceuticals earnings date
Q2 26/2712 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage